117 related articles for article (PubMed ID: 23377093)
1. Treatment of HIV and risk of multiple sclerosis.
Nexø BA; Pedersen L; Sørensen HT; Koch-Henriksen N
Epidemiology; 2013 Mar; 24(2):331-2. PubMed ID: 23377093
[No Abstract] [Full Text] [Related]
2. HIV and risk of venous thromboembolism: a Danish nationwide population-based cohort study.
Rasmussen LD; Dybdal M; Gerstoft J; Kronborg G; Larsen CS; Pedersen C; Pedersen G; Jensen J; Pedersen L; Sørensen HT; Obel N
HIV Med; 2011 Apr; 12(4):202-10. PubMed ID: 20726905
[TBL] [Abstract][Full Text] [Related]
3. The incidence rate of HIV type-1 drug resistance in patients on antiretroviral therapy: a nationwide population-based Danish cohort study 1999-2005.
Audelin AM; Lohse N; Obel N; Gerstoft J; Jørgensen LB
Antivir Ther; 2009; 14(7):995-1000. PubMed ID: 19918103
[TBL] [Abstract][Full Text] [Related]
4. Hospitalization for pneumonia among individuals with and without HIV infection, 1995-2007: a Danish population-based, nationwide cohort study.
Sogaard OS; Lohse N; Gerstoft J; Kronborg G; Ostergaard L; Pedersen C; Pedersen G; Sørensen HT; Obel N
Clin Infect Dis; 2008 Nov; 47(10):1345-53. PubMed ID: 18834317
[TBL] [Abstract][Full Text] [Related]
5. Cohort profile: the Danish HIV cohort study.
Obel N; Engsig FN; Rasmussen LD; Larsen MV; Omland LH; Sørensen HT
Int J Epidemiol; 2009 Oct; 38(5):1202-6. PubMed ID: 18799495
[No Abstract] [Full Text] [Related]
6. Risk of cataract surgery in HIV-infected individuals: a Danish Nationwide Population-based cohort study.
Rasmussen LD; Kessel L; Molander LD; Pedersen C; Gerstoft J; Kronborg G; Obel N
Clin Infect Dis; 2011 Dec; 53(11):1156-63. PubMed ID: 21998282
[TBL] [Abstract][Full Text] [Related]
7. Risk of high-level viraemia in HIV-infected patients on successful antiretroviral treatment for more than 6 months.
Engsig FN; Omland LH; Larsen MV; Rasmussen LD; Qvist T; Gerstoft J; Obel N
HIV Med; 2010 Aug; 11(7):457-61. PubMed ID: 20158527
[TBL] [Abstract][Full Text] [Related]
8. Non-typhoidal Salmonella and Campylobacter infections among HIV-positive patients in Denmark.
Larsen IK; Gradel KO; Helms M; Hornstrup MK; Jürgens G; Mens H; Rosager CL; Clausen TH; Kronborg G; Nielsen H
Scand J Infect Dis; 2011 Jan; 43(1):3-7. PubMed ID: 20849366
[TBL] [Abstract][Full Text] [Related]
9. Multiple sclerosis remission following antiretroviral therapy in an HIV-infected man.
Chalkley J; Berger JR
J Neurovirol; 2014 Dec; 20(6):640-3. PubMed ID: 25366658
[No Abstract] [Full Text] [Related]
10. The effectiveness of highly active antiretroviral therapy in HIV-infected patients.
Jensen-Fangel S
Dan Med Bull; 2004 Nov; 51(4):371-92. PubMed ID: 16009063
[No Abstract] [Full Text] [Related]
11. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
Clifford GM; Polesel J; Rickenbach M; Dal Maso L; Keiser O; Kofler A; Rapiti E; Levi F; Jundt G; Fisch T; Bordoni A; De Weck D; Franceschi S;
J Natl Cancer Inst; 2005 Mar; 97(6):425-32. PubMed ID: 15770006
[TBL] [Abstract][Full Text] [Related]
12. Multiple sclerosis after infectious mononucleosis.
Nielsen TR; Rostgaard K; Nielsen NM; Koch-Henriksen N; Haahr S; Sørensen PS; Hjalgrim H
Arch Neurol; 2007 Jan; 64(1):72-5. PubMed ID: 17210811
[TBL] [Abstract][Full Text] [Related]
13. [Premature arteriosclerosis in HIV-infected patients? Current status].
Hoffmann C
Herz; 2005 Sep; 30(6):467-71. PubMed ID: 16170676
[TBL] [Abstract][Full Text] [Related]
14. Trends in opportunistic infections in the pre- and post-highly active antiretroviral therapy eras among HIV-infected children in the Perinatal AIDS Collaborative Transmission Study, 1986-2004.
Nesheim SR; Kapogiannis BG; Soe MM; Sullivan KM; Abrams E; Farley J; Palumbo P; Koenig LJ; Bulterys M
Pediatrics; 2007 Jul; 120(1):100-9. PubMed ID: 17606567
[TBL] [Abstract][Full Text] [Related]
15. Summaries for patients. Comparison of survival among HIV-infected and noninfected people in Denmark, 1995-2005.
Ann Intern Med; 2007 Jan; 146(2):I39. PubMed ID: 17227931
[No Abstract] [Full Text] [Related]
16. Trends in bacteremia in the pre- and post-highly active antiretroviral therapy era among HIV-infected children in the US Perinatal AIDS Collaborative Transmission Study (1986-2004).
Kapogiannis BG; Soe MM; Nesheim SR; Sullivan KM; Abrams E; Farley J; Palumbo P; Koenig LJ; Bulterys M
Pediatrics; 2008 May; 121(5):e1229-39. PubMed ID: 18450865
[TBL] [Abstract][Full Text] [Related]
17. Incidence and prognosis of CMV disease in HIV-infected patients before and after introduction of combination antiretroviral therapy.
Salzberger B; Hartmann P; Hanses F; Uyanik B; Cornely OA; Wöhrmann A; Fätkenheuer G
Infection; 2005 Oct; 33(5-6):345-9. PubMed ID: 16258865
[TBL] [Abstract][Full Text] [Related]
18. Thymic involvement in recovery of immunity among HIV-infected adults on highly active antiretroviral therapy.
de la Rosa R; Leal M
J Antimicrob Chemother; 2003 Aug; 52(2):155-8. PubMed ID: 12837739
[No Abstract] [Full Text] [Related]
19. Cerebrovascular ischemic events in HIV-1-infected patients receiving highly active antiretroviral therapy: incidence and risk factors.
Corral I; Quereda C; Moreno A; Pérez-Elías MJ; Dronda F; Casado JL; Muriel A; Masjuán J; Alonso-de-Leciñana M; Moreno S
Cerebrovasc Dis; 2009; 27(6):559-63. PubMed ID: 19390181
[TBL] [Abstract][Full Text] [Related]
20. Cluster of multiple sclerosis patients from Danish community.
Haahr S; Munch M; Christensen T; Møller-Larsen A; Hvas J
Lancet; 1997 Mar; 349(9056):923. PubMed ID: 9093258
[No Abstract] [Full Text] [Related]
[Next] [New Search]
